Text size Jeenah Moon / Getty Images Pfizer hopes to get emergency food authorization from the Food and Drug Administration for its Covid-19 vaccine, produced in collaboration with BioNTech, in October – a timeline that is possible, and not the only positive for the biotech industry, according to a Mizuho …
Read More »Pfizer vaccine on track for regulatory review in October
Johnson & Johnson adds debt frenzy, borrowing $ 7.5 billion to buy Momenta
The Johnson & Johnson logo is displayed outside the company’s headquarters in New Brunswick, NJ Bloomberg News Johnson & Johnson on Thursday announced their top AAA credit ratings to borrow $ 7.5 billion in cheap financing for their acquisition of Momenta Pharmaceuticals, Inc. J&J, which makes drugs, consumables and medical …
Read More »A tidal wave of news about covid vaccine is on the market
Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »CureVac and EU in advanced talks for 225 million doses of Covid-19 vaccine
Shares of CureVac NV rose Thursday after the German biotech company said it was in advanced talks to deliver at least 225 million doses of a potential Covid-19 vaccine to EU member states. CureVac said talks with the EC, the executive arm of the European Union, include an option to …
Read More »